Zurbriggen A, Yamada M, Thomas C, Fujinami R S
Department of Pathology, University of California, San Diego, La Jolla 92093.
J Virol. 1991 Feb;65(2):1023-30. doi: 10.1128/JVI.65.2.1023-1030.1991.
The Daniels strain of Theiler's murine encephalomyelitis produces a chronic disease which is an animal model for human demyelinating disorders. Previously, we selected a neutralization-resistant virus variant producing an altered and diminished central nervous system disease in immunocompetent mice which was evident during the later stage of infection (after 4 weeks) (A. Zurbriggen and R. S. Fujinami, J. Virol. 63:1505-1513, 1989). The exact epitope determining neurovirulence was precisely mapped to a capsid protein, VP-1, and represents a neutralizing region (A. Zurbriggen, J. M. Hogle, and R. S. Fujinami, J. Exp. Med. 170:2037-2049, 1989). Here, we present experiments with immunoincompetent animals to determine viral replication, spread, and targeting to the central nervous system in the absence of detectable antibodies or functional T cells. Nude mice were infected orally, and the virus was monitored by plaque assay, immunohistochemistry, and in situ hybridization. Early during the infection (1 week), the variant virus induced an acute disease comparable to that induced by the wild-type virus in these nude mice. Alterations in tropism in the central nervous system were not apparent when wild-type parental Daniels strain virus was compared with the variant virus. Moreover, variant virus replicated in tissue culture (BHK-21 cells) to similarly high titers in a time course identical to that of the wild-type virus (A. Zurbriggen and R. S. Fujinami, J. Virol. 63:1505-1513, 1989). However, replication of the variant virus versus the wild-type virus within the spinal cord of athymic nude mice infected per os was substantially restricted by 6 weeks postinfection. Therefore, the reduced neurovirulence in the later stage (6 weeks) of the disease is most likely due to a diminished growth rate or spread of the variant virus in the central nervous system rather than to marked differences in viral tropism.
泰勒氏小鼠脑脊髓炎的丹尼尔斯毒株会引发一种慢性疾病,它是人类脱髓鞘疾病的动物模型。此前,我们筛选出了一种抗中和病毒变体,该变体在免疫功能正常的小鼠中引发的中枢神经系统疾病有所改变且症状减轻,这种情况在感染后期(4周后)较为明显(A. 祖布里根和R. S. 藤浪,《病毒学杂志》63:1505 - 1513, 1989年)。确定神经毒力的精确表位被精准定位到一种衣壳蛋白VP - 1上,并且它代表一个中和区域(A. 祖布里根、J. M. 霍格尔和R. S. 藤浪,《实验医学杂志》170:2037 - 2049, 1989年)。在此,我们用免疫功能不全的动物进行实验,以确定在不存在可检测抗体或功能性T细胞的情况下病毒的复制、传播以及在中枢神经系统中的靶向情况。给裸鼠进行口服感染,并通过噬斑测定、免疫组织化学和原位杂交来监测病毒。在感染早期(1周),这种变体病毒在这些裸鼠中引发的急性疾病与野生型病毒引发的类似。当将野生型亲本丹尼尔斯毒株病毒与变体病毒进行比较时,中枢神经系统中的嗜性改变并不明显。此外,变体病毒在组织培养(BHK - 21细胞)中的复制情况与野生型病毒在相同时间进程内的复制情况类似,达到了同样高的滴度(A. 祖布里根和R. S. 藤浪,《病毒学杂志》63:1505 - 1513, 1989年)。然而,在经口感染的无胸腺裸鼠的脊髓中,感染6周后变体病毒相对于野生型病毒的复制受到了显著限制。因此,在疾病后期(6周)神经毒力降低很可能是由于变体病毒在中枢神经系统中的生长速率或传播能力减弱,而非病毒嗜性存在显著差异。